CalciMedica is trading 6.4% up at $1.98, although available evidence does not establish a definitive catalyst.
- No clear company-specific announcement dated September 22, 2026 was identified.
- Latest reported developments were its September 8 investor-conference announcement and September 15 Nasdaq compliance restoration.
- The broader market is modestly positive, while the Nasdaq is up only 0.48%.